Genotyping is a method of determining genetic make-up differences of an individual by examining the individual’s DNA sequence using the biological assays and for comparing it to other individual’s sequence or a reference. The genotyping market is expected to have a CAGR of 23% during the forecast period 2016-2023.The key trend for the genotyping market is technological advancements as including chips that accommodate 1 million SNP assays, as well as these developments have been resulted in the explosion of positive whole-genome association and identification of many new genes for the common diseases. The utilities of SNP arrays for detecting and diagnosis structural variation through the development of genotyping algorithms is reviewed as well as methods for long-range haplotyping are presented. The drivers for the global genotyping market are rising developments in technologies, declining prices of DNA sequencing, rising prevalence of genetic diseases and rising personalized medicine.
Increasing developments in technologies, declining prices of DNA sequencing, growing prevalence of genetic diseases such as hemophilia, thalassemia etc., rising importance of SNP genotyping for the drug development process and rising demand for genome exploration in animal and plant livestock are the major factors that are increasing the growth in the global genotyping market. Moreover, the increasing demand for personalized medicine due to increasing aging population across the globe is also impacting the growth of the global market. The world is currently on the edge of undertaking a demographic milestone. Subsequently the establishment of history being recorded, young children previously were ahead of the number of people aged 65 or more will go down in the coming future. The change is motivated by dropping fertility rates and noteworthy rise in life expectancy, population aging is expected to continue, even accelerate in the next 10 years. The total people aged 65 or older are projected to rise from an assessed 524 million in year 2010 to almost 1.5 billion by 2050, with most of the increase in developing countries. As per WHO the world aged population is estimated to reach 2 billion by the end of 2050 that is 900 million in 2015. The remarkable improvements in life expectancy over the past century were part of a shift in the leading causes of disease and death. The rising prevalence of chronic life style oriented diseases is also increasing the growth in the global genotyping market. According to WHO, by the end of 2020 there will be around 15 million people suffering from cancer which has increased by around 50%. However, nonexistence of suitable reimbursement policies, lack of technical expertise and high cost of research and development are the major factors that are hampering the growth of global genotyping market. Moreover, there are some factors such as increasing access to healthcare & rising investment in emerging markets, rising demand for reasonably priced genotyping services, escalating application extents of genotyping and rising demand from emerging economies are creating huge opportunities in the global genotyping market.
Source: OBRC Analysis.
The report on global genotyping market includes technology, product, application and end-user.
Technology is segmented into:
- Capillary Electrophoresis
- Mass Spectrometry
- Microarray
- Polymerase Chain Reaction (PCR)
- Sequencing
- Others
Product of genotyping includes:
- Instruments
- Reagents And Kits
- Services
Application of genotyping includes:
- Academic Research
- Agriculture
- Diagnostics
- Drug Discovery And Development
- Personalized Medicine
- Others
The revenue for the above application segments is specific to the genotyping market. However, the total revenue of these application in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up technology and product segment.
The global genotyping market report has been geographically segmented in:
- North America (U.S. & Canada)
- Asia Pacific (China, India, Japan, RoAPAC)
- Europe (UK, France, Germany, RoE)
- Rest of World
Global genotyping market is segmented on the basis of technology, product, application and geography. The technology segment is segmented into polymerase chain reaction (PCR), capillary electrophoresis, mass spectrometry, sequencing, and microarray and others. The application segment is sub-segmented into diagnostics, drug discovery and development, personalized medicine, academic research, agriculture and others. The product segment is sub-segmented into instrument, reagents and kits and services. Polymerase Chain Reaction (PCR) is the important technology that is being used by researchers and healthcare professionals for precise and fast detection of genetic changes. The introduction of innovative Polymerase Chain Reaction (PCR) technologies in combination with computer programs, such as inverse PCR, reverse transcription PCR, assembly PCR and Quantitative PCR (Q-PCR) is also anticipated to driving the market growth. Sequencing is expected to be the fastest growing technology segment. Numerous advances in the present sequencing technologies have changed sequencing into a flexible, multilayered molecular tool.
On the basis of geography North America, Europe, Asia Pacific and ROW are the major segments. The North America held the largest market share around 32% in 2015 and dominated the global market followed by Europe, Asia Pacific and ROW in the global Genotyping market. The growth in North America market is majorly driven by the presence of some key player of genotyping who are investing a huge amount for the development of new technology in the genome development which is increasing the North America share in the Global genotyping market. The growth of North America is driven by number of factors such as Declining Prices of DNA Sequencing, Growing Prevalence of Genetic Diseases, rising funding from private and government for new technological advancement in genotyping technology and increasing demand for the personalized medicine in the North American region. Asia Pacific market is expected to grow with a high CAGR in forecasted period. The demand in the Asia Pacific region is majorly driven by rising demand for personalized medicine for the treatment due to increasing number of patient population in the region and increasing prevalence of chronic owing to change in the lifestyle and increase in the disposable income of the people. Moreover, the growing aging population in the emerging countries such as India and China is creating huge demand for the low cost treatment in the region and driving the growth in the global market.
The major market players of the global genotyping market are:
- GE HEALTHCARE
- GENETIC HEALTH
- ILLUMINA INC
- QIAGEN NV
- THERMO FISHER SCIENTIFIC
- OTHERS
These companies use various strategies such as merger & acquisition, collaboration, partnership and product launch. Whereas, merger & acquisition is the key strategy adopted by the companies in the genotyping market.
For Example: Illumina, lnc, Warburg pincus and hill ventures together formed a company on 18thaugust 2015. This partnership empowered consumers to interact with their own DNA. Helix enabled individuals to acquire genetic information by providing affordable sequencing and database services. Also, Affymetrix acquired assets of Eureka Genomics Corporation in May 2015.
The report covers detailed analysis of companies which comprises of overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in genotyping market.
Key reasons to buy the report:
- The report includes market estimation, forecast and analysis for the year 2016-2023
- Report includes detailed analysis of different segments such astype and applications of genotyping.
- Identify and understand the strengths, opportunities, challenges and threats of the genotyping market.
- Covers details analysis of Porters 5 force model and other strategic models and also covers revenues, market share analysis, and competitive landscape analysis of major players of global genotyping market.
- Detailed analysis of various regulatory policies which affect the global genotyping market.
How we are different from others:
At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global genotyping market offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the genotyping market, with giving extensive SCOT analysisof key companies.
Key findings of the global genotyping market:
- North America held highest revenue share in 2016.
- Sequencing is held the large revenue share in 2016 due to technological advancement and wide application area of DNA sequencing
- Personalized medicine is the major segment of application.
- Partnership is the key strategy adopted by players of global genotyping market.
